Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 56.80
-1.75 (-2.99%)
At close: Apr 23, 2025, 2:57 PM CST
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 68.89M CNY in the quarter ending September 30, 2024, with 14.70% growth. This brings the company's revenue in the last twelve months to 276.03M, up 36.80% year-over-year. In the year 2023, Medprin Regenerative Medical Technologies had annual revenue of 230.87M with 18.24% growth.
Revenue (ttm)
276.03M
Revenue Growth
+36.80%
P/S Ratio
14.48
Revenue / Employee
992.92K
Employees
278
Market Cap
4.00B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |